Spero Therapeutics (SPRO) Interest & Investment Income (2017 - 2026)
Spero Therapeutics (SPRO) reported Interest & Investment Income of $336000.0 for Q1 2026, down 61.11% on a YoY basis from $864000.0 in Q1 2025, and down 10.64% quarter-over-quarter from $376000.0 in Q4 2025.
Spero Therapeutics (SPRO) Interest & Investment Income (2017 - 2026) Analysis & Trends
Spero Therapeutics has reported Interest & Investment Income for 10 years, with the latest figure at $336000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income fell 61.11% year-over-year to $336000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 53.56% YoY), and the FY2025 full-year result was $2.5 million, down 46.95% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $336000.0, down from $376000.0 in the prior quarter.
- The five-year high for Interest & Investment Income was $1.3 million in Q1 2024, with the low at $72000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $742764.7 across 5 years, with a median of $864000.0 in 2025.
- Annual changes were most pronounced in 2023 — Interest & Investment Income jumped 1237.5% — and 2025, when it slumped 63.42%.
- Spero Therapeutics' Interest & Investment Income stood at $715000.0 in 2022, then jumped by 45.87% to $1.0 million in 2023, then dropped by 1.44% to $1.0 million in 2024, then tumbled by 63.42% to $376000.0 in 2025, then dropped by 10.64% to $336000.0 in 2026.
- The last three Interest & Investment Income figures came in at $336000.0 (Q1 2026), $376000.0 (Q4 2025), and $532000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Spero Therapeutics | 129.74 Mn | 73.61 Mn | - | 336,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 336,000.00 |
| Dec 31, 2025 | 376,000.00 |
| Sep 30, 2025 | 532,000.00 |
| Jun 30, 2025 | 740,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 950,000.00 |
| Jun 30, 2023 | 982,000.00 |
| Mar 31, 2023 | 963,000.00 |
| Dec 31, 2022 | 715,000.00 |
| Sep 30, 2022 | 208,000.00 |
| Jun 30, 2022 | 111,000.00 |
| Mar 31, 2022 | 72,000.00 |
| Dec 31, 2021 | 76,000.00 |
| Sep 30, 2021 | 90,000.00 |
| Jun 30, 2021 | 82,000.00 |